All Relations between Dermatomyositis and ab

Publication Sentence Publish Date Extraction Date Species
Sung Won Chang, Kyung Hoon Min, Sung Yong Lee, Jae Jeong Shim, Gyu-Young Hu. Rapid Progression of Acute Interstitial Pneumonia in a Patient with Low MDA-5 Antibody Titer. The American journal of case reports. vol 25. 2024-07-04. PMID:38961608. first, when treating rapidly progressing interstitial pneumonia of an unknown cause, it is recommended to consider lung involvement of mda-5 ab dermatomyositis. 2024-07-04 2024-07-10 Not clear
Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fuji. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports. 2024-04-10. PMID:38597870. herein, we report a rare case of a 49-year-old woman with anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab)-positive dermatomyositis (dm), which developed five weeks after the introduction of an etanercept biosimilar to rheumatoid arthritis (ra). 2024-04-10 2024-04-12 Not clear
Toshiyuki Shiki Ushijima, Toshihiko Komai, Shinji Izuka, Hirofumi Shoda, Keishi Fuji. Characteristics of anti-melanoma differentiation associated gene 5 antibody-positive dermatomyositis with thrombotic microangiopathy. Modern rheumatology. 2024-02-12. PMID:38343273. anti-melanoma differentiation associated gene 5 antibody (anti-mda5 ab)-positive dermatomyositis (dm) is representative of rapidly progressive interstitial pneumonia. 2024-02-12 2024-02-15 Not clear
Tomoka Watanabe, Misaki Taniguchi, Sanae Ogura, Mea Asou, Shunsuke Takayanagi, Yuko Sokai, Yoshiki Tsuji, Keita P Mori, Tomomi Endo, Toshiki Nakajima, Yoshitaka Imura, Tatsuo Tsukamot. Effectiveness and safety of plasma exchange for anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2024-01-16. PMID:38225794. clinically amyopathic dermatomyositis (cadm) with anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab) with rapidly progressive interstitial lung disease (rp-ild) is often refractory for intensive immunosuppression. 2024-01-16 2024-01-18 Not clear
Choon Guan Chua, Jia Zhen Low, Wei Yen Lim, Mona Manghan. Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore. Annals of the Academy of Medicine, Singapore. vol 51. issue 12. 2023-01-02. PMID:36592144. this study aimed to determine the clinical profile and outcome of anti-transcriptional intermediary factor 1 gamma autoantibody (anti-tif1-γ ab)-positive dermatomyositis patients and propose cancer screening programmes based on regional cancer trends. 2023-01-02 2023-08-14 Not clear
Anaïs Nombel, Jean-Jacques Pin, Nicole Fabien, Pierre Miossec, Frédéric Coutan. Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies. Biomedicines. vol 10. issue 11. 2022-11-26. PMID:36428536. anti-melanoma differentiation-associated protein 5 (mda5) antibody (ab) positive dermatomyositis (anti-mda5 dm) is a rare systemic autoimmune disease; further, its prognosis can be rapidly fatal due to pulmonary involvement. 2022-11-26 2023-08-14 human
Frédéric Coutant, Rafael Bachet, Jean-Jacques Pin, Marina Alonzo, Pierre Miosse. Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production. Journal of autoimmunity. vol 130. 2022-04-18. PMID:35436746. anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab) positive dermatomyositis (anti-mda5 dm) is a rare entity associated with poor prognosis and multiple immunologic abnormalities. 2022-04-18 2023-08-13 Not clear
Geng Wang, Qian Wang, Yeming Wang, Changzheng Liu, Linghang Wang, Hong Chen, Tao Jiao, Chaojun Hu, Xiaobo Lei, Li Guo, Lili Ren, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Dingyu Zhang, Bin Cao, Jianwei Wan. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. Frontiers in immunology. vol 12. 2022-01-06. PMID:34987516. striking similarities have been found between coronavirus disease 2019 (covid-19) and anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab)-related dermatomyositis, implying a shared autoinflammatory aberrance. 2022-01-06 2023-08-13 Not clear
Akira Yamagata, Machiko Arita, Ayaka Tanaka, Fumiaki Tokioka, Tomohiro Yoshida, Keisuke Nishimura, Tadashi Ishid. Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia. Journal of clinical apheresis. vol 35. issue 5. 2021-11-03. PMID:32810902. patients with clinically amyopathic dermatomyositis (cadm) with anti-melanoma differentiation-associated gene 5 antibody (anti-mda5 ab) frequently develop rapidly progressive interstitial pneumonia (rpip), often with fatal outcomes. 2021-11-03 2023-08-13 Not clear
Qian Zhao, Yongheng Chen, Licheng Diao, Shimin Zhang, Dan Wu, Feng Xue, Qunli Xia, Hao Li, Jie Zheng, Hua Ca. Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody. Rheumatology (Oxford, England). 2021-09-11. PMID:34508564. dermatomyositis (dm) and clinically amyopathic dermatomyositis (cadm) patients with positive expression of anti-transcription intermediary factor 1-γ (anti-tif1-γ) antibody (ab) are characterized by distinct clinicopathological features. 2021-09-11 2023-08-13 Not clear
Sei-Ichiro Motegi, Akiko Sekiguchi, Hidekazu Ikeuchi, Toru Sakairi, Hiroomi Ogawa, Takaaki Fujii, Makoto Sohda, Toshiki Yajima, Shota Ida, Yukihiro Takayasu, Yuki Shimoda, Keiju Hiromura, Hiroshi Saeki, Ken Shirabe, Kazuaki Chikamatsu, Hideaki Yokoo, Tetsunari Oyama, Osamu Ishikaw. Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis. The Journal of dermatology. vol 47. issue 12. 2021-05-14. PMID:32734678. anti-transcription intermediary factor 1γ (anti-tif1γ) antibody (ab) is significantly associated with internal malignancies in adult patients with dermatomyositis (dm). 2021-05-14 2023-08-13 Not clear
Mengmeng Zhou, Yan Ye, Ninghui Yan, Xinyue Lian, Chunde Bao, Qiang Gu. Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis. Clinical rheumatology. vol 39. issue 6. 2021-02-16. PMID:31942657. anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab)-positive clinically amyopathic dermatomyositis (cadm) with pneumomediastinum (pnm) is a life-threatening condition. 2021-02-16 2023-08-13 Not clear
Hiroyuki Kagawa, Kazuyuki Tsujino, Yuji Yamamoto, Ami Iwai, Reina Hara, Takanori Matsuki, Kiyoharu Fukushima, Yohei Oshitani, Kenji Yoshimura, Mari Miki, Keisuke Miki, Seigo Kitada, Masahide Mori, Hiroshi Kid. Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease:A case report. Respiratory medicine case reports. vol 29. 2020-09-28. PMID:32055439. the presence of anti-melanoma differentiation-associated gene 5 antibody (anti-mda5 ab) is closely associated with rapidly progressive interstitial lung disease (rp-ild) in patients with clinically amyopathic dermatomyositis. 2020-09-28 2023-08-13 Not clear
Kyoko Shimizu, Tadahiro Kobayashi, Miyu Kano, Yasuhito Hamaguchi, Kazuhiko Takehara, Takashi Matsushit. Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis. The Journal of dermatology. vol 47. issue 1. 2020-09-25. PMID:31638280. the presence of anti-transcriptional intermediary factor (tif)1-γ antibody (ab) is associated with cancer in adult patients with clinically amyopathic dermatomyositis (cadm) or dermatomyositis (dm). 2020-09-25 2023-08-13 Not clear
Yuichi Ishikawa, Tadamichi Kasuya, Michio Fujiwara, Yasuhiko Kit. Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report. Medicine. vol 99. issue 37. 2020-09-24. PMID:32925726. antimelanoma differentiation-associated gene 5 antibody (anti-mda5 ab)-positive clinically amyopathic dermatomyositis (cadm) is frequently complicated with interstitial lung disease (ild) and has a poor prognosis. 2020-09-24 2023-08-13 Not clear
Tsuyoshi Watanabe, Naoho Takizawa, Toru Nagasaka, Yoshihiro Nakamura, Hiroki Ikai, Mari Yamamoto, Yukari Murai, Koji Takasugi, Waka Yokoyama-Kokuryo, Yoshiro Fujit. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report. Medicine. vol 99. issue 3. 2020-02-18. PMID:32011440. anti-melanoma differentiation-associated gene 5 antibody (anti-mda5 ab) is an autoantigen associated with dermatomyositis (dm). 2020-02-18 2023-08-13 Not clear
Ho So, Victor Tak Lung Wong, Virginia Weng Nga Lao, Hin Ting Pang, Ronald Man Lung Yi. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis. Clinical rheumatology. vol 37. issue 7. 2018-10-29. PMID:29713969. to report our experience in using rituximab (rtx) for treating refractory rapidly progressive interstitial lung disease (rp-ild) complicating anti-melanoma differentiation-associated gene 5 antibody (anti-mda5 ab)-positive amyopathic dermatomyositis (adm). 2018-10-29 2023-08-13 Not clear
Ho So, Ricky W-K Ip, Victor T-L Wong, Ronald M-L Yi. Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations. International journal of rheumatic diseases. vol 21. issue 5. 2018-10-15. PMID:29380533. to compare the prevalence of the anti-melanoma differentiation-associated gene 5 antibody (anti-mda5 ab) in hong kong chinese patients with dermatomyositis (dm) and polymyositis (pm); in addition, to examine the association of anti-mda5 ab and the clinical characteristics of these patients. 2018-10-15 2023-08-13 Not clear
Yushiro Endo, Tomohiro Koga, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana, Yuji Hosono, Tsuneyo Mimori, Atsushi Kawakam. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report. Medicine. vol 97. issue 26. 2018-07-09. PMID:29952940. among all dermatomyositis (dm) patients, antimelanoma differentiation-associated gene 5 antibody (anti-mda5 ab) positive patients have significantly poor short-term mortality, whereas they experience less relapses over the long term after the remission. 2018-07-09 2023-08-13 Not clear
Youhei Fujiki, Takuya Kotani, Kentaro Isoda, Takaaki Ishida, Takeshi Shoda, Shuzo Yoshida, Tohru Takeuchi, Shigeki Makin. Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Modern rheumatology. vol 28. issue 1. 2018-07-05. PMID:28490218. we retrospectively investigated clinical prognostic factors for interstitial pneumonia (ip) in anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab)-positive dermatomyositis (dm) patients. 2018-07-05 2023-08-13 Not clear